A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects with Narcolepsy Type 1 (ALKS 2680-201)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
The purpose of this research study is to assess the safety and efficacy of ALKS 2680 compared to placebo, including whether participants taking ALKS 2680 experience a greater decrease in sleepiness and a decrease in cataplexy (\"sudden loss of muscle control\"), compared to participants taking placebo alone.
Epistemonikos ID: 641c38085912d9682b79fba06d7f8c6887c95e66
First added on: May 15, 2024